As the S&P 500 approaches it's former highs, the Nasdaq 100 has moved above former highs and is exhibiting a strong uptrend. Healthcare, propelled by the biotechnology industry, is one of the leading sectors in this overall uptrend, and has been for more than a year. These stocks continue show strength and have recently seen another surge to the upside. Price action and a couple indicators are looked at come up with scenarios of what's next for these four stocks on a tear.

Jazz Pharmaceuticals (Nasdaq:JAZZ) has tripled in price over the last year, and accelerated to the upside on February 18, jumping 7.38%. Price shows no signs of reversing yet, although indicators are flashing caution. RSI and MACD are both showing divergence; this does not mean a reversal is immanent though. The MCD is still making higher highs and is getting pinched between the two trend lines, which means it could break higher as well. Price drops to the trendline area still present buying opportunities, and it takes a drop below $140 to warn that price may be entering a deeper correction or reversal. Profit targets between $10 and $15 above a former high have worked well for swing trades over the last several months.

Illumina (Nasdaq:ILMN) is strong on all accounts--the price is moving strongly and the indicators are also near highs. As the trend has accelerated in 2014, short-term traders may be looking for an exit if the price drops below the short-term trendline at $160. If that occurs a deeper pullback is likely. The longer-term trend is still in effect though. $135 to $125 is an area of potential support, providing a buying area for medium-term traders. When the price makes a new high it has typically moved at least $5 beyond it (before pulling back again); this may aid in picking a target for futures trades. If the short-term trendline holds look for more of the quick pullbacks and snaps higher, similar to what's occurred over the last two months.

Valeant Pharmaceuticals (NYSE:VRX) recently made new highs, after breaking out of a small consolidation. $140--the high of the consolidation should provide support and a buying region on pullbacks. Upside target is $157.75 for the current wave. Longer-term targets can be moved up as long as the price is making higher highs and higher lows. A drop below $130 would signal a larger correction or reversal is underway. RSI and MACD are both showing a divergence; looking at the price we can see the current price wave higher is not as strong the strong price surge seen in early January. This is what causes the divergence and doesn't indicate the trend is over, just that is has slowed compared to the prior wave.

Biogen Idec (Nasdaq:BIIB) broke out of a meandering price channel in late 2013 and has been chopping it's way higher since. $20 pullbacks are quite common since the start of the year, followed by $30 to $40 moves higher. These pullbacks provide buying opportunities, and look like they could align with the trendline currently near $310. The recent price waves can be used establish a target should an entry develop; that target is likely to be in the $350 region. RSI and MACD are once again diverging with the price, making lower highs. This again shows the price is action is not as strong as it was back in late November when there saw a big gap higher, but the uptrend is still effect. It remains in effect until the price breaks below a former low. Currently that is $392.53.

The Bottom Line

These stocks are all showing strong price action with uptrends well underway. Price is what ultimately matters--as long as the price is creating higher swing highs and higher swing lows, the uptrend is in tact. Indicators can forewarn of potential reversals, yet the price would need to make a lower high or lower low to validate the signal. Divergence can occur simply because a current price run (wave) is not as strong as a prior run. In strong stocks this can often occur and doesn't necessarily mean an imminent reversal. That said, when there is a very strong run to the upside, at some point there will be profit taking which will result in a decline. Risk and position size should always be tailored to your personal risk tolerance and situation.

Disclosure - At the time of writing, the author did not own shares of any company mentioned in this article.

Related Articles
  1. Chart Advisor

    Four Chart Patterns To Watch This Week

    This week is likley to reveal if the S&P 500 is in a consolidation with the expectation of a move higher, or if it's topping out. Here's four ways to play either scenario.
  2. Chart Advisor

    Gold Struggles to Climb Higher and May Fall Soon

    Traders will be watching the price of gold over the coming weeks. We'll take a look at how a couple major moving averages are suggesting that the next move could be lower.
  3. Technical Indicators

    Use Market Volume Data to Determine a Bottom

    Market bottoms often carve out classic volume patterns that let observant traders make fast and accurate calls.
  4. Stock Analysis

    Net Neutrality: Pros and Cons

    The fight over net neutrality has become an amazing spectacle. But at its core, it's yet another skirmish in cable television's war to remain relevant.
  5. Charts & Patterns

    Understand How Square Works before the IPO

    Square is reported to have filed for an IPO. For interested investors wondering how the company makes money, Investopedia takes a look at its business.
  6. Trading Strategies

    Who Actually Trades or Invests In Penny Stocks?

    Although penny stocks are highly speculative, millions of people trade them daily. Here are 10 different types who do.
  7. Chart Advisor

    4 Stocks Still Flashing Buy Signals

    In the midst of volatility and a big market sell-off last week, these stocks are flashing buy signals.
  8. Technical Indicators

    Understanding Trend Analysis

    Trend analysis is the use of past performance to predict future price movement of a security.
  9. Personal Finance

    A Day in the Life of an Equity Research Analyst

    What does an equity research analyst do on an everyday basis?
  10. Mutual Funds & ETFs

    ETF Analysis: PowerShares S&P 500 Downside Hedged

    Find out about the PowerShares S&P 500 Downside Hedged ETF, and learn detailed information about characteristics, suitability and recommendations of it.
RELATED TERMS
  1. Equity

    The value of an asset less the value of all liabilities on that ...
  2. Fintech

    Fintech is a portmanteau of financial technology that describes ...
  3. Indicator

    Indicators are statistics used to measure current conditions ...
  4. Intraday Momentum Index (IMI)

    A technical indicator that combines aspects of candlestick analysis ...
  5. Hard-To-Sell Asset

    An asset that is extremely difficult to dispose of either due ...
  6. Sucker Yield

    When an investor has essentially risked all of his capital for ...
RELATED FAQS
  1. Tame Panic Selling with the Exhausted Selling Model

    The exhausted selling model is a pricing strategy used to identify and trade based off of the price floor of a security. ... Read Full Answer >>
  2. Point and Figure Charting Using Count Analysis

    Count analysis is a means of interpreting point and figure charts to measure vertical price movements. Technical analysts ... Read Full Answer >>
  3. What assumptions are made when conducting a t-test?

    The common assumptions made when doing a t-test include those regarding the scale of measurement, random sampling, normality ... Read Full Answer >>
  4. What is the difference between called-up share capital and paid-up share capital?

    The difference between called-up share capital and paid-up share capital is investors have already paid in full for paid-up ... Read Full Answer >>
  5. Why would a corporation issue convertible bonds?

    A convertible bond represents a hybrid security that has bond and equity features; this type of bond allows the conversion ... Read Full Answer >>
  6. How does additional paid in capital affect retained earnings?

    Both additional paid-in capital and retained earnings are entries under the shareholders' equity section of a company's balance ... Read Full Answer >>

You May Also Like

COMPANIES IN THIS ARTICLE
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!